The UCLA-CURE Digestive Disease Core Center is organized around a cohesive group of senior investigators who have strong independent research programs in upper gastrointestinal tract biology and/or mucosal disease. Specifically, these investigators are studying the role of peptide hormones and neuropeptides in regulation of gastric secretion, blood flow and emptying; regulation of parietal cell function and the biochemical mechanisms responsible for acid secretion; mechanisms for cellular transport of essential nutrients, including glucose, and of cytoprotective substances, particularly glutathione; and control of acute bleeding from peptic ulcers and long term prevention of recurrent ulcer disease. The major functions of the Center are to foster productive scientific interactions between members of the research groups, to develop new programs, and to provide a milieu in which young investigators can enhance their training and develop their careers. The six scientific cores outlined in this proposal provide ready access to technology and to clinical biological materials that are essential to the programs of Center members. These cores provide custom synthesis of peptides and methods for purifying and characterizing them including custom antibody production; sophisticated animal models for studies of gastric secretion, motor function, and blood flow; anatomical methods for identification of proteins, mRNA, and receptors; and imaging techniques to study intracellular responses to modifiers of cellular function as well as a clinical studies core. An administrative core provides general coordination of Center activities and additionally offers to all members computer and graphics services, grants management, and a dynamic enrichment program. Six pilot and feasibility study proposals add an innovative dimension to the Center's research parameters. Funding of this center grant will provide the resources and the environment to ensure enhanced collaborations among investigators. In addition, it will provide the milieu for a coordinated comprehensive training program that can take young investigators through a continuum from postdoctoral fellowships, through the invaluable experience of carrying out a pilot and feasibility study, to the ultimate goal of developing independent laboratory programs. Finally, a cohesive center setting allows a creative enrichment program to prosper. CURE investigators already have made a major impact in the peptic disease/mucosal biology field during the last 15 years. The Center will offer new areas of emphasis, relevant to the current interests of the participants, better organization, and a renewed spirit of cooperative interaction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK041301-04
Application #
3102162
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1990-01-15
Project End
1994-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hoffman, Jill M; Sideri, Aristea; Ruiz, Jonathan J et al. (2018) Mesenteric Adipose-derived Stromal Cells From Crohn's Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis. Cell Mol Gastroenterol Hepatol 6:1-16
Bonfiglio, Ferdinando; Zheng, Tenghao; Garcia-Etxebarria, Koldo et al. (2018) Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology 155:168-179
Wen, Yi; Scott, David R; Vagin, Olga et al. (2018) Measurement of Internal pH in Helicobacter pylori by Using Green Fluorescent Protein Fluorimetry. J Bacteriol 200:
Kageyama, Shoichi; Nakamura, Kojiro; Fujii, Takehiro et al. (2018) Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside. Hepatology 68:258-273
Wang, Jiani; Ghali, Sally; Xu, Chunlan et al. (2018) Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Gastroenterology 154:1737-1750
Koon, Hon Wai; Wang, Jiani; Mussatto, Caroline C et al. (2018) Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-?B Activity. Antimicrob Agents Chemother 62:
Rankin, Carl Robert; Theodorou, Evangelos; Man Law, Ivy Ka et al. (2018) Identification of novel mRNAs and lncRNAs associated with mouse experimental colitis and human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 315:G722-G733
Manatsathit, Wuttiporn; Khrucharoen, Usah; Jensen, Dennis M et al. (2018) Laparotomy and intraoperative enteroscopy for obscure gastrointestinal bleeding before and after the era of video capsule endoscopy and deep enteroscopy: A tertiary center experience. Am J Surg 215:603-609
Dong, Tien; Pisegna, Joseph (2018) Passing the ""Acid Test"": Do Proton Pump Inhibitors Affect the Composition of the Microbiome? Dig Dis Sci :
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:

Showing the most recent 10 out of 1097 publications